Singapore markets close in 3 hours 43 minutes

Anavex Life Sciences Corp. (0HFR.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
4.4600-0.0650 (-1.44%)
At close: 05:40PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3-43.99%
S&P500 52-week change 328.04%
52-week high 310.4460
52-week low 30.0000
50-day moving average 35.7899
200-day moving average 37.2401

Share statistics

Avg vol (3-month) 37.78k
Avg vol (10-day) 33.92k
Shares outstanding 545.43M
Implied shares outstanding 6N/A
Float 882.05M
% held by insiders 13.05%
% held by institutions 138.13%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-19.63%
Return on equity (ttm)-28.98%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-40.59M
Diluted EPS (ttm)-0.5790
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)139.39M
Total cash per share (mrq)1.65
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)15.12
Book value per share (mrq)1.61

Cash flow statement

Operating cash flow (ttm)-32.48M
Levered free cash flow (ttm)-21.69M